Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002379
What this trial is testing

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Gilead Sciences 100
Large-scale testing (Phase 3)Study completedNCT00013897
What this trial is testing

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00005779
What this trial is testing

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Post-approval studies (Phase 4)Study completedNCT00005106
What this trial is testing

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome 230
Early research (Phase 1)Study completedNCT00001766
What this trial is testing

Drug Interactions Among Anti-HIV Agents

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00014014
What this trial is testing

Zidovudine and Lamivudine Given Once Versus Twice Daily

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Not applicableStudy completedNCT00002177
What this trial is testing

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableStudy completedNCT00001102
What this trial is testing

The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Testing effectiveness (Phase 2)WithdrawnNCT00008866
What this trial is testing

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Testing effectiveness (Phase 2)Study completedNCT00031044
What this trial is testing

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00001095
What this trial is testing

Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Large-scale testing (Phase 3)Study completedNCT00004978
What this trial is testing

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,150
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00000897
What this trial is testing

Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00000887
What this trial is testing

Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00000867
What this trial is testing

Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

Who this might be right for
AIDS Dementia ComplexHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT00266058
What this trial is testing

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Who this might be right for
HIV InfectionsMalaria
University of California, San Francisco 33
Testing effectiveness (Phase 2)Study completedNCT00002234
What this trial is testing

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 25
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation